You are here

Article info

Article menu

Download PDFPDF

Review
Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials

Authors

  • Malena Daich Varela UCL Institute of Ophthalmology, University College London, London, UK Moorfields Eye Hospital NHS Foundation Trust, London, London, UK PubMed articlesGoogle scholar articles
  • Thales Antonio Cabral de Guimaraes UCL Institute of Ophthalmology, University College London, London, UK Moorfields Eye Hospital NHS Foundation Trust, London, London, UK PubMed articlesGoogle scholar articles
  • Michalis Georgiou UCL Institute of Ophthalmology, University College London, London, UK Moorfields Eye Hospital NHS Foundation Trust, London, London, UK PubMed articlesGoogle scholar articles
  • Michel Michaelides UCL Institute of Ophthalmology, University College London, London, UK Moorfields Eye Hospital NHS Foundation Trust, London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Michel Michaelides, University College London, London EC1V 9EL, UK; michel.michaelides{at}ucl.ac.uk
View Full Text

Citation

Daich Varela M, Cabral de Guimaraes TA, Georgiou M, et al
Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials
British Journal of Ophthalmology 2022;106:445-451.

Publication history

  • Received November 21, 2020
  • Revised January 18, 2021
  • Accepted February 23, 2021
  • First published March 12, 2021.
Online issue publication 
March 22, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.